WIPOSchützen Sie diese Marke vor Nachahmern!
Mit unserer Markenüberwachung werden Sie automatisch per E-Mail über Nachahmer und Trittbrettfahrer benachrichtigt.
Die Internationale Marke SENZAGEN wurde als Wortmarke am 17.11.2017 bei der Weltorganisation für geistiges Eigentum angemeldet.
| Markenform | Wortmarke |
| Aktenzeichen | 1465990 |
| Länder | 
|
| Basismarke |
Nr. 016749749,
19. Mai 2017
|
| Anmeldedatum | 17. November 2017 |
| Ablaufdatum | 17. November 2027 |
Markeninhaber
Medicon Village,
Scheelevägen 2
SE
Scheelevägen 2
SE
Markenvertreter
Chapel Quarter,
Mount Street
GB
Waren und Dienstleistungen
01
Diagnostic preparations for analytical, research and
scientific use; assays for analytical, research and
scientific use; diagnostic biomarkers for analytical,
research and scientific use; diagnostic preparations, assays
and biomarkers for use in in vitro testing, assessment of
toxicological properties of chemical compounds and mixtures,
genomic analysis, assessment of chemical skin sensitizers,
respiratory sensitizers and potency classification, for
scientific testing and screening purposes; diagnostic
preparations, assays and biomarkers for screening of
pharmaceutical candidates, safety and potency classification
of chemicals, safety and potency testing of cosmetic
ingredients and assessment of sensitizers for industry and
regulatory purposes, for scientific testing and screening
purposes
05
Diagnostic preparations for medical and pharmaceutical use;
assays for medical and pharmaceutical use; diagnostic
biomarkers for medical and pharmaceutical use; diagnostic
preparations, assays and biomarkers for use in in vitro
testing, assessment of toxicological properties of chemical
compounds and mixtures, genomic analysis, assessment of
chemical skin sensitizers, respiratory sensitizers and
potency classification all for medical and pharmaceutical
testing and screening purposes; diagnostic preparations,
assays and biomarkers for screening of pharmaceutical
candidates, safety and potency classification of chemicals,
safety and potency testing of cosmetic ingredients and
assessment of sensitizers for industry and regulatory
purposes in the medical and pharmaceutical industries, all
for medical and pharmaceutical testing and screening
purposes
42
Scientific and technological services and research and
design relating thereto; industrial analysis and research
services; scientific research and development; conducting
research in the field of genomics and animal-free testing;
laboratory services in the field of genomics and animal-free
testing; in vitro analysis for medical and pharmaceutical
purposes; in vitro analysis for medical, pharmaceutical and
scientific research services; assessment of toxicological
properties of chemical compounds and mixtures, for medical,
pharmaceutical and scientific research services; dermal and
respiratory in vitro analysis for medical pharmaceutical and
scientific research services; in vitro skin and respiratory
sensitization analysis for medical, pharmaceutical and
scientific research services; in vitro safety assessments
for medical, pharmaceutical and scientific research
services; in vitro testing for assessment of chemical skin
sensitizers, respiratory sensitizers and potency
classification; allergy analysis for medical, pharmaceutical
and scientific research services; animal-free allergy
analysis for medical, pharmaceutical and scientific research
services; allergy analysis and animal-free allergy analysis
for medical and pharmaceutical purposes; development of
sensitization assays for prediction and classification of
chemical sensitizers; safety and potency classification of
chemicals for medical, pharmaceutical and scientific
research services; safety and potency testing of cosmetic
ingredients; assessment of sensitizers for industry and
regulatory purposes in the medical and pharmaceutical
industries; safety assessments of chemicals and proteins in
the medical and pharmaceutical industries; in vitro
assessment of allergens in the medical and pharmaceutical
industries; sensitization testing for the pharmaceutical,
cosmetic and chemical industry; information, advisory and
consultancy services relating to all of the aforesaid
services; assessment of toxicological properties of chemical
compounds and mixtures for medical and pharmaceutical
purposes; animal-free testing of chemical compounds, genomic
testing, animal-free genomic testing, dermal and respiratory
in vitro testing and analysis, in vitro skin and respiratory
sensitization testing and analysis, in vitro safety
assessments, testing and assessment of sensitizers, in vitro
testing for assessment of chemical skin sensitizers,
respiratory sensitizers and potency classification, all for
medical and pharmaceutical purposes; screening of
pharmaceutical candidates, safety and potency classification
of chemicals, safety and potency testing of cosmetic
ingredients and assessment of sensitizers for industry and
regulatory purposes in the medical and pharmaceutical
industries; safety assessments of chemicals and proteins, in
vitro assessment of allergens, all for medical and
pharmaceutical purposes; sensitization testing for the
pharmaceutical and cosmetic industries; in vitro testing; in
vitro testing of medical devices
44
In vitro testing for medical and pharmaceutical purposes;
allergy testing, animal-free allergy testing, all for
medical and pharmaceutical purposes; information, advisory
and consultancy services relating to all of the aforesaid
services
Die Bezeichnungen wurden automatisch übersetzt. Übersetzung anzeigen
Markenhistorie
| Datum | Belegnummer | Bereich | Eintrag |
|---|---|---|---|
| 23. Juli 2021 | 2021/31 Gaz | KR | RAW: Rule 18ter(2)(ii) GP following a provisional refusal |
| 22. April 2021 | 2021/17 Gaz | JP | RAW: Rule 18ter(2)(ii) GP following a provisional refusal |
| 13. Februar 2021 | 2021/7 Gaz | US | RAW: Rule 18ter(2)(ii) GP following a provisional refusal |
| 05. November 2020 | 2020/46 Gaz | CN | Ablehnung |
| 05. November 2020 | 2020/46 Gaz | KR | Ablehnung |
| 17. September 2020 | 2020/38 Gaz | JP | Ablehnung |
| 29. April 2020 | 2020/28 Gaz | EM | RAW: Partial Ceasing Effect |
| 03. Februar 2020 | 2020/27 Gaz | IL | RAW: Rule 18ter(2)(ii) GP following a provisional refusal |
| 23. Januar 2020 | 2020/7 Gaz | KR | Ablehnung |
| 02. Dezember 2019 | 2020/27 Gaz | IN | Ablehnung |
| 19. November 2019 | 2020/27 Gaz | AU | Ablehnung |
| 03. September 2019 | 2019/42 Gaz | NZ | Ablehnung |
| 01. Juli 2019 | 2019/32 Gaz | CN | Ablehnung |
| 08. Juni 2019 | 2019/25 Gaz | US | Ablehnung |
| 03. Juni 2019 | 2019/24 Gaz | IL | Ablehnung |
| 17. November 2017 | EM | Eintragung |
ID: 141465990